MAPLEWOOD, Mo. — After Missouri voters added abortion protections to the state constitution in 2024, Kelly McCoomb decided to keep her yard sign supporting the measure in the basement of her suburban St. Louis home. Abortion access is important to McCoomb. She wants her daughter to grow up in a state where the option is…
I spent some time figuring out and getting a little help in uploading my health records to Claude, using HealthEx. I did the demo with Ruheed Mohamed, the head of technical services, and then I interviewed CEO Priyanka Agarwal, MD. This shows how Healthex gets data and incorporates it into Claude, and where Priyanka thinks…
CertifyOS launched a shared credentialing program that allows providers to submit their information once for multiple health plans. The post UHC, Cigna and Centene Sign On to New National Shared Credentialing Program appeared first on MedCity News.
Eli Lilly’s partnership with InnoCare Pharma follows deals struck this year with other China-based companies. While indications for the new alliance remain undisclosed, InnoCare specializes in oncology and autoimmune drugs. The post Lilly Again Looks to China for New Drugs, Paying InnoCare $100M to Start R&D Pact appeared first on MedCity News.
A Data Explorer tool helps clinical and administrative teams monitor performance against quality measures and identify care gaps
Healthcare has a habit of embracing patient empowerment right up until patients become powerful. The post From OpenNotes to “Doc Can I Record You?” Why Physicians Should Embrace Era of Accountability appeared first on MedCity News.
Prior to the Joint Commission, Merlino served as chief clinical transformation officer at Cleveland Clinic
The Centers for Medicare & Medicaid Services (CMS) took constructive steps in its 2027 final rule and rate announcement, particularly on payment integrity and quality measurement. But those steps are not the finish line. Policymakers should further modernize MA to strengthen competition, transparency and accountability. Here’s where to start. The post Modernizing Medicare Advantage for…
Informatics leader conceptualized and implemented the first offering of the AMIA 10×10 program
TrumpRx prices for brand-name drugs are about as likely to be higher as lower compared to average prices in other wealthy countries, according to an analysis that compares 32 brand-name drugs (without generics or biosimilars) on the TrumpRx website with publicly available prices in one or more of 11 OECD member countries.